UPDATE: Pfizer books Arena for immuno-inflammatory portfolio in $6.7B deal
UPDATE: Pfizer books Arena for immuno-inflammatory portfolio in $6.7B deal [...]
Super-fit mice reveal anti-inflammatory protein that could boost search for Alzheimer’s drugs
Super-fit mice reveal anti-inflammatory protein that could boost search for [...]
Moderna, hoping to prove it’s no one-trick COVID pony, posts early peek at mRNA flu shot hopeful
Moderna, hoping to prove it’s no one-trick COVID pony, posts [...]
Eli Lilly pens $1.5B biobucks pact with China’s Regor for metabolic disease work
Eli Lilly pens $1.5B biobucks pact with China’s Regor for [...]
Roche posts ‘impressive’ TIGIT combo lung cancer data, but trial deaths weigh down shares
Roche posts ‘impressive’ TIGIT combo lung cancer data, but trial [...]
Novartis poaches Roche’s neuro and rare disease R&D lead, replacing Shanker
Novartis poaches Roche’s neuro and rare disease R&D lead, replacing [...]
Albireo CMO Horn is out the door 5 months after US, EU approvals of rare liver disease drug
Albireo CMO Horn is out the door 5 months after [...]
Nanomedicine shrinks vascular lesions in mice and could pave path to new treatments
Nanomedicine shrinks vascular lesions in mice and could pave path [...]
ASH: 2 years in, the survival data on J&J’s rival to Bristol Myers’ BCMA cell therapy are still growing
ASH: 2 years in, the survival data on J&J’s rival [...]
K36 emerges with $30M to bankroll multiple myeloma drug in-licensed from Novartis
K36 emerges with $30M to bankroll multiple myeloma drug in-licensed [...]